Search company, investor...

Nokwon C&I

nokwoncni.co.kr

Founded Year

1995

Stage

Reverse Merger | IPO

About Nokwon C&I

Nokwon C&I (KRX: 065560) is a printing material company that produces ink.

Headquarters Location

7-12 Sinchon 2-ro

Paju,

South Korea

Missing: Nokwon C&I's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nokwon C&I's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Nokwon C&I News

Cubes acquires Nokwon C&I

Apr 22, 2020

PUBLISHED :June 02, 2017 - 09:30 UPDATED :June 02, 2017 - 09:30 [DISCLOSURE] Cubes (065560) announced on June 1 that it has decided to acquire entire stake of Nokwon C&I, a printing material company, at 51 billion won (US$45.48 million) to enter new business and to diversify profitability. This amounts to 304.51 percent of its equity capital. By Hwang You-mee ( theinvestor@heraldcorp.com )

Nokwon C&I Frequently Asked Questions (FAQ)

  • When was Nokwon C&I founded?

    Nokwon C&I was founded in 1995.

  • Where is Nokwon C&I's headquarters?

    Nokwon C&I's headquarters is located at 7-12 Sinchon 2-ro, Paju.

  • What is Nokwon C&I's latest funding round?

    Nokwon C&I's latest funding round is Reverse Merger.

  • Who are the investors of Nokwon C&I?

    Investors of Nokwon C&I include CUBES.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.